Royce & Associates LP lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 23.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,650 shares of the medical instruments supplier’s stock after purchasing an additional 24,000 shares during the quarter. Royce & Associates LP owned 0.06% of DENTSPLY SIRONA worth $8,212,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Alps Advisors Inc. grew its stake in shares of DENTSPLY SIRONA by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 7,523 shares of the medical instruments supplier’s stock worth $488,000 after purchasing an additional 20 shares during the period. Ropes Wealth Advisors LLC grew its stake in shares of DENTSPLY SIRONA by 0.3% during the 1st quarter. Ropes Wealth Advisors LLC now owns 9,003 shares of the medical instruments supplier’s stock worth $562,000 after purchasing an additional 29 shares during the period. Wetherby Asset Management Inc. grew its stake in shares of DENTSPLY SIRONA by 0.6% during the 2nd quarter. Wetherby Asset Management Inc. now owns 5,004 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 30 shares during the period. HighTower Advisors LLC grew its stake in shares of DENTSPLY SIRONA by 0.6% during the 1st quarter. HighTower Advisors LLC now owns 6,823 shares of the medical instruments supplier’s stock worth $424,000 after purchasing an additional 39 shares during the period. Finally, Atria Investments LLC grew its stake in shares of DENTSPLY SIRONA by 1.5% during the 2nd quarter. Atria Investments LLC now owns 4,541 shares of the medical instruments supplier’s stock worth $294,000 after purchasing an additional 68 shares during the period. 93.97% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Royce & Associates LP Has $8.21 Million Stake in DENTSPLY SIRONA Inc. (XRAY)” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.thecerbatgem.com/2017/09/04/royce-associates-lp-has-8-21-million-stake-in-dentsply-sirona-inc-xray.html.

XRAY has been the topic of a number of analyst reports. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and dropped their price objective for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. BidaskClub lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, June 10th. HC Wainwright initiated coverage on DENTSPLY SIRONA in a research report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price on the stock. Finally, Credit Suisse Group reiterated an “outperform” rating and set a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. Three research analysts have rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $66.08.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 56.66 on Monday. The stock’s market cap is $13.00 billion. The stock’s 50 day moving average price is $58.75 and its 200-day moving average price is $62.00. DENTSPLY SIRONA Inc. has a 12 month low of $52.53 and a 12 month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.65. The firm had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.76 earnings per share. Equities research analysts predict that DENTSPLY SIRONA Inc. will post $2.68 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be issued a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -10.09%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Stock Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related stocks with our FREE daily email newsletter.